Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers
about
What is the impact of biologic therapies on common co-morbidities in patients with rheumatoid arthritis?Biologics registers in RA: methodological aspects, current role and future applications.A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: challenges and opportunitiesRisk of Cancer in Patients with Psoriasis on Biologic Therapies: A Systematic Review.Malignancy Incidence, Management, and Prevention in Patients with Rheumatoid Arthritis.Clinical Signs, Pathophysiology and Management of Cutaneous Side Effects of Anti-Tumor Necrosis Factor Agents.Methotrexate increases the risk of melanoma: or does it?Treatment with Biologicals in Rheumatoid Arthritis: An Overview.Effect of nobiletin on the MAPK/NF-κB signaling pathway in the synovial membrane of rats with arthritis induced by collagen.Malignancy Risk and Recurrence with Psoriasis and its Treatments: A Concise Update.Skin Manifestations of Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Spondyloarthritides.Skin cancer associated with commonly prescribed drugs: tumor necrosis factor alpha inhibitors (TNF-αIs), angiotensin-receptor blockers (ARBs), phosphodiesterase type 5 inhibitors (PDE5Is) and statins -weighing the evidence.Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example.TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer
P2860
Q28074148-041E709E-32E2-425A-AF0F-E050A4948F26Q30234303-C0365870-02C6-4A5E-A31D-BCA346E1C0B7Q33576975-1E677670-422B-499B-B8DF-C09FBB5DFC4BQ38672588-F1DD107A-6179-4324-A2F4-CCF690793D1BQ39309064-0339C618-B95C-466D-A7F8-D4EBA2B6BA55Q39361308-5FFD19A9-41D7-4982-8BDC-BB228D0696CEQ40172889-FD516119-1C64-4300-AEE4-A15243B24DF5Q47132835-D44235DC-049A-430F-BB0D-15BC206F6FB3Q47379129-70D55ED9-480A-458B-823A-00C61157671AQ48089393-1D945E78-3FAC-4F41-8A4D-B9FD3B05643FQ48332071-46620860-AC1A-44BE-A847-4EB0D060FD57Q50155389-3827C9A9-4A34-49CE-8B94-50605D936A94Q55338290-F09CA9B7-2DDF-44E0-BDB8-BAEB65C19A53Q58621104-A54A0BCF-1E57-4EED-BB00-8D33CE811EA1
P2860
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Risk of invasive melanoma in p ...... 11 European biologic registers
@en
Risk of invasive melanoma in p ...... 1 European biologic registers.
@nl
type
label
Risk of invasive melanoma in p ...... 11 European biologic registers
@en
Risk of invasive melanoma in p ...... 1 European biologic registers.
@nl
prefLabel
Risk of invasive melanoma in p ...... 11 European biologic registers
@en
Risk of invasive melanoma in p ...... 1 European biologic registers.
@nl
P2093
P2860
P50
P1476
Risk of invasive melanoma in p ...... 11 European biologic registers
@en
P2093
Angela Zink
Anja Strangfeld
Axel Finckh
Jacques Morel
Jacques-Eric Gottenberg
Joachim Listing
Johan Askling
Lene Dreyer
Louise K Mercer
Pauline Raaschou
P2860
P304
P356
10.1136/ANNRHEUMDIS-2016-209285
P407
P577
2016-06-15T00:00:00Z